Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/
You can print this page and show it to your doctor.

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

ProPublica's Dollars for Docs database lets you search for payments to U.S.-based doctors made by pharmaceutical and medical device companies between August 2013 and December 2018. The disclosure of these payments is required under the Physician Payments Sunshine Act, a provision of the 2010 Affordable Care Act.

About This Information

  • The information that appears here comes directly from the federal government. Companies must attest to its accuracy, and doctors have the ability to contest information they believe is in error.
  • This site includes payments for such activities as speaking, consulting, meals, travel and royalties. It does not include payments for clinical research.
  • It is legal for companies to make payments to doctors as long as the payments are not a kickback or inducement to use their products.
  • Some doctors say collaborative relationships, particularly those involving research, are necessary to develop new treatments and cures. But many ethicists have raised questions about the payments, and studies show that they may influence doctors' prescribing decisions.
  • Only you can decide if this matters to you and if so, whether you want to talk with your doctor about it. If you plan to talk with your doctor (or if you already have), please help us by filling out this short survey: propub.li/participate-d4d

Preparing for Your Conversation

If you decide you'd like to talk to your doctor about this, please keep in mind:

  • Many health care professionals in our database have similar names, so you should start by asking your doctor if the person mentioned in this payment record is really him/her.
  • Your doctor may not know he or she is listed as receiving payments, especially if the payments are small. You can direct your doctor to this site (the URL will be printed at the top of the payment record) or directly to the government's site here: https://openpaymentsdata.cms.gov/physician/335114
  • Some doctors are happy to discuss this information with you. Others might not be. The best approach is to ask questions and to not be accusatory.

Questions You Might Want to Ask

  • Is this you?
  • What type of work do you do with these companies?
  • Have you prescribed me any drugs that are manufactured by companies you've taken payments from?
  • Are there non-drug alternatives that I may want to consider first?
  • Are there less expensive generic alternatives to the drugs you have prescribed?
  • What devices have you used in my care that are manufactured by companies you've taken payments from?

Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/doctors/pid/335114
If you spot an error, please let us know at [email protected].

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

PETER MCCULLOUGH

Listed Specialty: Cardiovascular Disease
621 N HALL ST, H030, DALLAS, TX, 75226-1339

2018 Payments: At a Glance

357

payments

$280,160

payment total

26

companies paid this doctor

Types of Payments

Category Payments Payment Value
Promotional Speaking/Other
 51 $121K
Consulting
 42 $113K
Travel and Lodging
 108 $39,621
Food and Beverage
 155 $6,259
Education
 1 $5

Drugs & Devices in 2018

Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.

Product Name Product Type Payments†
REPATHA

drug

 $57,203
Payments with no listed product

N/A

 $56,831
INVOKANA

drug

 $46,868
PRALUENT

drug

 $42,405
FARXIGA

drug

 $21,858
STEGLATRO

drug

 $20,274
ARCHITECT SYSTEM

device

 $9,218
LOKELMA

drug

 $7,304
JUXTAPID

drug

 $6,044
OZEMPIC

drug

 $4,040
GZ402671

drug

 $2,876
ACZ885M

drug

 $1,255
AQUADEX

device

 $1,200
SYSTEM ONE

device

 $748
ZYPITAMAG

drug

 $690
AURYXIA

drug

 $450
BRILINTA

drug

 $200
ELIQUIS

drug

 $199
ENTRESTO

drug

 $150
VICTOZA

drug

 $118
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products.

For ease of printing, only the 20 drugs and devices with the highest payments are displayed. For a complete list, please visit: https://projects.propublica.org/docdollars/doctors/pid/335114

Payment Details

When How Much Related To What For From Third Party Payee
May 25, 2018 $10,225 No Listed Product Travel and Lodging ASTRAZENECA AB
Jun 13, 2018 $8,063 No Listed Product Consulting EDWARDS LIFESCIENCES CORPORATION
Sep 6, 2018 $7,260 PRALUENT Promotional Speaking/Other REGENERON HEALTHCARE SOLUTIONS, INC. Premier Advisory and Consulting Services LLC
Jun 11, 2018 $6,534 PRALUENT Promotional Speaking/Other REGENERON HEALTHCARE SOLUTIONS, INC. Premier Advisory and Consulting Services LLC
Feb 12, 2018 $6,534 PRALUENT Promotional Speaking/Other REGENERON HEALTHCARE SOLUTIONS, INC. Premier Advisory and Consulting Services LLC
Nov 14, 2018 $6,094 No Listed Product Consulting EDWARDS LIFESCIENCES CORPORATION
Nov 7, 2018 $5,840 INVOKANA Consulting JANSSEN PHARMACEUTICALS, INC Premier Advisory and Consulting Services, LLC
Nov 16, 2018 $5,500 INVOKANA Consulting JANSSEN SCIENTIFIC AFFAIRS, LLC
Dec 18, 2018 $5,500 REPATHA Consulting AMGEN INC. PREMIER ADVISORY AND CONSULTINGSERVICES LLC
Mar 17, 2018 $5,400 INVOKANA Consulting JANSSEN SCIENTIFIC AFFAIRS, LLC Premier Advisory & Consulting Services
Nov 8, 2018 $5,375 STEGLATRO Consulting MERCK SHARP & DOHME CORPORATION PREMIER CONSULTING AND ADVISORY SERVICES INC
May 3, 2018 $5,350 No Listed Product Consulting ASTRAZENECA PHARMACEUTICALS LP
Jun 27, 2018 $5,350 LOKELMA Consulting ASTRAZENECA PHARMACEUTICALS LP
Mar 16, 2018 $5,300 JUXTAPID Consulting AEGERION PHARMACEUTICALS, INC.
Apr 2, 2018 $4,650 No Listed Product Consulting MERCK SHARP & DOHME CORPORATION PREMIER ADVISORY AND CONSULTING SERVICES, LLC
May 16, 2018 $4,600 INVOKANA Promotional Speaking/Other JANSSEN PHARMACEUTICALS, INC Premier Advisory and Consulting Services, LLC
Feb 28, 2018 $4,600 INVOKANA Promotional Speaking/Other JANSSEN PHARMACEUTICALS, INC Premier Advisory and Consulting Services, LLC
Nov 16, 2018 $4,600 INVOKANA Promotional Speaking/Other JANSSEN PHARMACEUTICALS, INC Premier Advisory and Consulting Services, LLC
Nov 25, 2018 $4,565 FARXIGA Consulting ASTRAZENECA PHARMACEUTICALS LP
May 23, 2018 $4,400 REPATHA Consulting AMGEN INC. PREMIER ADVISORY AND CONSULTINGSERVICES LLC

For ease of printing, 20 payments are displayed, the largest appearing on top. For a full list of payments, please visit: https://projects.propublica.org/docdollars/doctors/pid/335114

Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].

This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.